Molybdenum oxide nanoparticles (MoOx, NPs) were successfully prepared by the pulsed laser ablation technique in water. Picosecond pulses allowed synthesizing chemically and morphologically stable MoOx colloidal nano-particles dispersed in water, which are used to fabricate modified screen printed carbon paste electrode (SPCE). The molybdenum oxide nanoparticles modified electrode (MoOx NPs/SPCE) shows enhanced electro-catalytic behavior for the detection of dopamine in Phosphate Buffered Saline (pH = 7) solution. Under the optimal conditions, the peak current of dopamine increased linearly with the concentration in the 0.1-600 mu M range, with a limit of detection (LOD) of 43 nM. The very easy MoOx NPs/SPCE fabrication, its high sensitivity, sub-micromolar detection limits and excellent selectivity towards main interferents, made them as a potential candidate for the detection of dopamine in pharmaceutical and clinical preparations.
Molybdenum oxide nanoparticles for the sensitive and selective detection of dopamine
Fazio, E.
Primo
;Spadaro, S.Secondo
;Bonsignore, M.;Leonardi, S. G.;Neri, G.Penultimo
;Neri, F.Ultimo
2018-01-01
Abstract
Molybdenum oxide nanoparticles (MoOx, NPs) were successfully prepared by the pulsed laser ablation technique in water. Picosecond pulses allowed synthesizing chemically and morphologically stable MoOx colloidal nano-particles dispersed in water, which are used to fabricate modified screen printed carbon paste electrode (SPCE). The molybdenum oxide nanoparticles modified electrode (MoOx NPs/SPCE) shows enhanced electro-catalytic behavior for the detection of dopamine in Phosphate Buffered Saline (pH = 7) solution. Under the optimal conditions, the peak current of dopamine increased linearly with the concentration in the 0.1-600 mu M range, with a limit of detection (LOD) of 43 nM. The very easy MoOx NPs/SPCE fabrication, its high sensitivity, sub-micromolar detection limits and excellent selectivity towards main interferents, made them as a potential candidate for the detection of dopamine in pharmaceutical and clinical preparations.File | Dimensione | Formato | |
---|---|---|---|
2018_jec_814_91–96.pdf
solo gestori archivio
Descrizione: Articolo principale
Tipologia:
Versione Editoriale (PDF)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
766.88 kB
Formato
Adobe PDF
|
766.88 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.